Boston University Spin-Out and Funding
The NanoView technology was spun-out from the Ünlü lab (https://www.bu.edu/eng/profile/selim-unlu/), where Dr. Freedman and Dr. Daaboul were researchers. The laboratory has a history of developing interferometric based biosensors since 2007. The laboratory received an NSF-AIR award (NSF-IIP #1127833) to develop and build the prototype NanoView platform.
NanoView has received support from the NSF through an SBIR Phase I grant (NSF-IIP #1448319). This grant allowed improvements in the NanoView technology. For more information on the the NSF seed fund program: https://seedfund.nsf.gov/
NanoView has also received support from the NIH through an SBIR Phase I grant. This grant is exploring the use of the ExoView platform for early diagnostic applications.
In February 2017 NanoView Biosciences completed a Series A funding to drive the commercial development of the ExoView technology. Series A funding has been used to accelerate product and assay development as well as to drive recruitment to commercialize the product.